IVOG Vanguard S&P Mid-Cap 400 Growth ETF
Quote as of Aug 26, 2026 19:59 UTC · Market data delayed approximately 15–20 minutes unless otherwise indicated.
| Previous Close | 142.56 | Day Range | 142.38 – 143.94 |
| 52-Week Range | 113.78 – 148.72 | Volume | 12.64K |
| Avg Volume | 25.59K | AUM | $1.80B (Aug 27, 2026) |
| Expense Ratio | 0.10% | Yield (TTM) | 0.54% |
| NAV | 143.67 | Premium/Discount | +0.11% indicative |
| Inception | Sep 07, 2010 | Holdings | 240 |
| Issuer | Vanguard | Exchange | AMEX |
| Category | Us Mid Cap | Index Tracked | S&P MidCap 400 |
| CUSIP | 921932869 | ISIN | US9219328690 |
| Management | Not stated in source data | ||
About this ETF
The Vanguard S&P Mid-Cap 400 Growth ETF (IVOG) allocates its capital to equities within the S&P MidCap 400 Growth Index, which is specifically designed to encompass growth-oriented companies drawn from the broader S&P 400. Its central objective is to meticulously replicate the performance of this index, which serves as a recognized benchmark for the overall U.S. mid-capitalization growth stock market. This fund offers considerable upside potential for capital appreciation, though its share value tends to fluctuate more dramatically than that of bond-focused investments. Consequently, it is best suited for individuals pursuing long-term financial goals where significant growth of their principal is paramount. It is noteworthy that on March 14, 2023, this ETF executed a 2-for-1 share split, which led to a reduction in its per-share price and a corresponding increase in the number of shares outstanding. Unless specifically noted as market data, historical share price information has not been retrospectively adjusted for this corporate action. While certain data presentations might display both pre- and post-split prices, it's important to understand that this event has no effect on the calculation of investment returns.
Description from the fund data provider · profile as of Aug 27, 2026.
Price Chart
Daily closing prices (price return, not total return). Comparison lines are normalized to percent change from the range start. Source: Financial Modeling Prep.
Performance
| 1M | 3M | 6M | YTD | 1Y | 3Y* | 5Y* | 10Y* | Incep.* | |
|---|---|---|---|---|---|---|---|---|---|
| Price return | +1.15% | +0.46% | +8.01% | +18.61% | +21.42% | +15.46% | +7.08% | +10.08% | +11.47% |
| Total return | +1.16% | +0.47% | +8.02% | +18.61% | +22.20% | +16.44% | +7.97% | +11.07% | +12.37% |
* Annualized. Total return uses the dividend-adjusted price series (distributions reinvested); price return uses unadjusted closes. Performance through Aug 25, 2026. Past performance does not guarantee future results.
Fees
| Net expense ratio | 0.10% | Annual cost of a $10,000 investment | $10.00 |
Illustrative calculation only: expense ratio × $10,000. It excludes trading costs, bid/ask spreads, taxes and changes in investment value. Gross vs. net expense details and any fee waivers are in the prospectus.
Holdings
Holdings as of Aug 25, 2026 — portfolio reporting date from the data provider; holdings are not live positions. 251 rows in database.
| # | Holding | Ticker | Weight | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | Twilio Inc | TWLO | 1.65% | 150.03K | $29.6M |
| 2 | TechnipFMC PLC | FTI | 1.57% | 394.12K | $28.2M |
| 3 | Curtiss-Wright Corp | CW | 1.47% | 36.52K | $26.4M |
| 4 | ATI Inc | ATI | 1.41% | 134.90K | $25.3M |
| 5 | nVent Electric PLC | NVT | 1.37% | 159.86K | $24.6M |
| 6 | Everpure Inc | P | 1.34% | 311.92K | $24.1M |
| 7 | Okta Inc | OKTA | 1.31% | 165.73K | $23.5M |
| 8 | XPO Inc | XPO | 1.30% | 116.06K | $23.3M |
| 9 | United Therapeutics Corp | UTHR | 1.21% | 41.96K | $21.7M |
| 10 | Tenet Healthcare Corp | THC | 1.21% | 85.15K | $21.7M |
| 11 | Woodward Inc | WWD | 1.18% | 58.90K | $21.2M |
| 12 | Carpenter Technology Corp | CRS | 1.13% | 39.11K | $20.3M |
| 13 | RB Global Inc | RBA | 1.12% | 184.16K | $20.2M |
| 14 | Roku Inc | ROKU | 1.05% | 129.68K | $18.8M |
| 15 | Sterling Infrastructure Inc | STRL | 1.01% | 30.33K | $18.1M |
| 16 | ITT Inc | ITT | 0.96% | 88.37K | $17.3M |
| 17 | RBC Bearings Inc | RBC | 0.96% | 31.18K | $17.2M |
| 18 | Neurocrine Biosciences Inc | NBIX | 0.92% | 99.39K | $16.6M |
| 19 | Illumina Inc | ILMN | 0.92% | 80.76K | $16.6M |
| 20 | MACOM Technology Solutions Holdings Inc | MTSI | 0.91% | 64.86K | $16.3M |
| 21 | MasTec Inc | MTZ | 0.89% | 60.91K | $16.0M |
| 22 | Royal Gold Inc | RGLD | 0.89% | 80.53K | $16.0M |
| 23 | Jazz Pharmaceuticals PLC | JAZZ | 0.87% | 62.02K | $15.7M |
| 24 | Fabrinet | FN | 0.86% | 35.42K | $15.4M |
| 25 | BWX Technologies Inc | BWXT | 0.85% | 90.56K | $15.3M |
Click a ticker to see every ETF that owns it.
Geographic Exposure
Country weights as reported by the data provider. Developed/emerging/frontier labels follow the classification on the Methodology page. Currency hedged: No hedging indicated in the fund name.
Distributions
| Yield (TTM) | 0.54% | Paid (last 12 months) | $0.7744 |
| Frequency | Annual | SEC yield | Not provided by our data source — see the issuer page |
| Last ex-date | Dec 22, 2025 | Last payment | $0.7744 (Dec 24, 2025) |
| Growth 1Y | -12.71% | Growth 3Y / 5Y (ann.) | -24.17% / -10.12% |
| Ex-date | Record | Pay date | Amount |
|---|---|---|---|
| Dec 22, 2025 | Dec 22, 2025 | Dec 24, 2025 | $0.7744 |
| Dec 23, 2024 | Dec 23, 2024 | Dec 26, 2024 | $0.8872 |
| Dec 20, 2023 | Dec 21, 2023 | Dec 26, 2023 | $1.1267 |
| Dec 20, 2022 | Dec 21, 2022 | Dec 23, 2022 | $1.7760 |
| Dec 21, 2021 | Dec 22, 2021 | Dec 27, 2021 | $1.0000 |
| Dec 22, 2020 | Dec 23, 2020 | Dec 28, 2020 | $1.3200 |
| Dec 16, 2019 | Dec 17, 2019 | Dec 19, 2019 | $1.7220 |
| Dec 13, 2018 | Dec 14, 2018 | Dec 18, 2018 | $1.1950 |
| Dec 19, 2017 | Dec 20, 2017 | Dec 22, 2017 | $1.2360 |
| Dec 20, 2016 | Dec 22, 2016 | Dec 27, 2016 | $1.1580 |
| Dec 17, 2015 | Dec 21, 2015 | Dec 23, 2015 | $1.0340 |
| Dec 22, 2014 | Dec 24, 2014 | Dec 29, 2014 | $0.7920 |
Trailing distribution yield = last 12 months of cash ÷ current price. It is NOT the SEC 30-day yield and distributions are not guaranteed to continue. The difference explained →
Risk Statistics
| Volatility 1Y / 3Y | 17.82% / 19.09% | Sharpe 1Y / 3Y | 1.15 / 0.785 |
| Max drawdown 1Y / 3Y | -9.69% / -25.61% | Sortino 1Y | 1.75 |
| Beta vs S&P 500 (3Y) | 1.07 | Correlation vs S&P 500 (1Y) | 0.824 |
| Downside deviation 1Y | 11.70% | Risk-free rate used | 3.72% (3M T-bill, FRED) |
Computed by ETF Explorer from daily dividend-adjusted closes; volatility and drawdown are annualized/period figures; S&P 500 exposure proxied by SPY. As of Aug 26, 2026. Formulas →
Liquidity
| Volume today | 12.64K | Average volume | 25.59K |
| AUM | $1.80B | Premium/Discount | +0.11% |
| Bid/Ask spread | Not provided by our data source. Check your broker's quote screen; spreads are widest at the open and close. | ||
Premium/discount compares the delayed market price with the last reported NAV — an indicative figure, not the official closing premium/discount. How ETF liquidity works →
Fund Flows (estimated)
| Period | Est. net flow | % of starting AUM | AUM start → end |
|---|---|---|---|
| 1 Day | $0.00 | 0.00% | $1.80B → $1.80B |
| 1 Week | $26.4M | +1.47% | $1.80B → $1.80B |
ETF Explorer estimate: change in reported AUM minus the market-move effect, from our own daily snapshots. Not official issuer creation/redemption data.
Official Fund Resources
External links open the issuer's site or SEC EDGAR in a new tab. The prospectus and official documents are always the authoritative source — review them before investing.
Latest News for IVOG
No articles mention this fund directly in the last 7 days — showing general ETF coverage.
Guided help: AUM is fund size. The expense ratio is the yearly cost baked into returns. NAV is the value of what the fund owns per share; the market price can sit slightly above (premium) or below (discount) it. Total return assumes distributions were reinvested. Every dataset shows its own as-of date because holdings, assets and quotes update on different schedules.